Niagen Bioscience, Inc. (NAGE) stock news · P/E 13, rev $129.4M
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
This NAGE news page leads with what Niagen Bioscience, Inc. filed — not a scraped headline mill.
No cached 8-K sentence for NAGE yet. We will not pad this page with generic market recap.
Latest reported NAGE revenue for 2025-12-31 was $129.4M. Net income was $17.4M. Revenue was up 29.9% from 2024-12-31 to 2025-12-31. NAGE currently screens at market cap $836.5M and trailing P/E 13.1.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the NAGE stock page; for the tape open the quote page.
NAGE stock news FAQ
What are NAGE's latest revenue and net income?
Latest cached Niagen Bioscience, Inc. (NAGE) revenue for Dec 31, 2025 was $129.4M. Net income was $17.4M. Statements: https://lician.com/financials/nage
How did NAGE revenue change from the prior cached period?
Cached Niagen Bioscience, Inc. (NAGE) revenue was up 29.9% from $99.6M (Dec 31, 2024) to $129.4M (Dec 31, 2025). Statements: https://lician.com/financials/nage
What is NAGE's P/E ratio?
Niagen Bioscience, Inc. (NAGE) trailing P/E is 13.1 on the latest cached fundamentals snapshot.
What is NAGE's market cap?
Niagen Bioscience, Inc. (NAGE) market cap is $836.5M on the latest cached fundamentals snapshot.
What kind of company is NAGE?
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
Where is NAGE stock news listed?
Cached stock news for Niagen Bioscience, Inc. (NAGE) is listed at https://lician.com/news/nage. Filings: https://lician.com/sec/nage
Not investment advice.